lsta: the income statement

MyFinsight

LISATA THERAPEUTICS, INC. (LSTA)

For the quarter ending 2025-06-30, LSTA made $70K in revenue. -$4,659K in net income. Net profit margin of -6655.71%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Revenue	70
General and administrative	2,685
Research and development	2,253
Total operating expenses	4,938
Operating loss	-4,868
Other expense, net	-7
Investment income, net	216
Total other income	209
Net loss before benefit from income taxes and noncontrolling interests	-4,659
Benefit from income taxes	-
Net loss	-4,659
Less - net income (loss) attributable to noncontrolling interests	-
Net loss attributable to lisata therapeutics, inc. common stockholders	-4,659

Basic shares (in shares)	8,605,000
Diluted shares (in shares)	8,605,000
Lisata therapeutics, inc. common stockholders - diluted (in usd per share)	-0.54
Lisata therapeutics, inc. common stockholders- basic (in usd per share)	-0.54

Unit: Thousand (K) dollars (except for numbers of shares and EPS)